Fluorodeoxyglucose-positron emission tomography disease activity assessment in patients with biopsy-proven giant cell arteritis

被引：0
|
作者：
Simo, M. [1 ]
Navales, I. [2 ]
Mestres, J. [1 ]
Martinez, F. [1 ]
Solans, R. [1 ]
Salcedo, M. [1 ]
Barios, M. [2 ]
Boronat, M. [2 ]
Castell, J. [1 ]
机构：
[1] Hosp Univ Vall Hebron, Barcelona, Spain
[2] Hosp Univ Vall Hebron, Unitat IDI, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0115
引用
收藏
页码：S479 / S479
页数：1
相关论文
共 50 条
  • [1] Fluorodeoxyglucose Positron Emission Tomography for Giant Cell Arteritis
    Blockmans, Daniel
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (12) : 1763 - 1764
  • [2] Thrombocytosis in patients with biopsy-proven giant cell arteritis
    Foroozan, R
    Danesh-Meyer, H
    Savino, PJ
    Gamble, G
    Mekari-Sabbagh, ON
    Sergott, RC
    OPHTHALMOLOGY, 2002, 109 (07) : 1267 - 1271
  • [3] Atherosclerosis in patients with biopsy-proven giant cell arteritis
    Gonzalez-Juanatey, Carlos
    Lopez-Diaz, Maria J.
    Martin, Javier
    Llorca, Javier
    Gonzalez-Gay, Miguel A.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (08): : 1481 - 1486
  • [4] Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study
    Prieto-Gonzalez, Sergio
    Depetris, Marina
    Garcia-Martinez, Ana
    Espigol-Frigole, Georgina
    Tavera-Bahillo, Itziar
    Corbera-Bellata, Marc
    Planas-Rigol, Ester
    Alba, Marco A.
    Hernandez-Rodriguez, Jose
    Grau, Josep M.
    Lomena, Franciso
    Cid, Maria C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (07) : 1388 - 1392
  • [5] Risk of cancer in patients with biopsy-proven giant cell arteritis
    Hill, Catherine L.
    Cole, Antonia
    Rischmueller, Maureen
    Dodd, Thomas
    Coleman, Mark
    Tucker, Graeme
    Roberts-Thomson, Peter
    RHEUMATOLOGY, 2010, 49 (04) : 756 - 759
  • [6] Reply: Fluorodeoxyglucose positron emission tomography for the diagnosis of giant cell arteritis
    Brodmann, M
    Pilger, E
    RHEUMATOLOGY, 2004, 43 (05) : 679 - 680
  • [7] NEUROLOGIC DISEASE IN BIOPSY-PROVEN GIANT-CELL (TEMPORAL) ARTERITIS
    CASELLI, RJ
    HUNDER, GG
    WHISNANT, JP
    NEUROLOGY, 1988, 38 (03) : 352 - 359
  • [8] CLINICAL MANIFESTATIONS OF BIOPSY-PROVEN GIANT CELL ARTERITIS
    WILSKE, KR
    HEALEY, LA
    ARTHRITIS AND RHEUMATISM, 1971, 14 (03): : 424 - &
  • [9] Recovery of visual function in patients with biopsy-proven giant cell arteritis
    Foroozan, R
    Deramo, VA
    Buono, LM
    Jayamanne, DGR
    Sergott, RC
    Danesh-Meyer, H
    Savino, PJ
    OPHTHALMOLOGY, 2003, 110 (03) : 539 - 542
  • [10] Use of 18F-fluorodeoxyglucose Positron Emission Tomography to Monitor Disease Activity in Patients With Giant Cell Arteritis on Tocilizumab
    Quinn, Kaitlin A.
    Ahlman, Mark A.
    Grayson, Peter C.
    ACR OPEN RHEUMATOLOGY, 2025, 7 (02)
12345